|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||||
| Investments: | ||||||||||||||||||||
| Fixed Maturities at Fair Value | ||||||||||||||||||||
| Consolidated Entity, Excluding VIE | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Consolidated Entity, Excluding Consolidated VIE | ||||||||||||||||||||
| Total fixed Maturities at Fair Value | ||||||||||||||||||||
| Equity Securities at Fair Value | ||||||||||||||||||||
| Consolidated Entity, Excluding VIE | ||||||||||||||||||||
| Total equity Securities at Fair Value | ||||||||||||||||||||
| Equity Securities at Modified Cost | ||||||||||||||||||||
| Equity Method Limited Liability Investments | ||||||||||||||||||||
| Alternative Energy Partnership Investments | ||||||||||||||||||||
| Equity Method Limited Liability Investments | ||||||||||||||||||||
| Consolidated Entity, Excluding VIE | ||||||||||||||||||||
| Total equity Method Limited Liability Investments | ||||||||||||||||||||
| Convertible Securities at Fair Value | ||||||||||||||||||||
| Short-term Investments at Cost which Approximates Fair Value | ||||||||||||||||||||
| Consolidated Entity, Excluding VIE | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Consolidated Entity, Excluding Consolidated VIE | ||||||||||||||||||||
| Total short-term Investments at Cost which Approximates Fair Value | ||||||||||||||||||||
| Company-Owned Life Insurance | ||||||||||||||||||||
| Consolidated Entity, Excluding VIE | ||||||||||||||||||||
| Total company-Owned Life Insurance | ||||||||||||||||||||
| Loans to Policyholders | ||||||||||||||||||||
| Consolidated Entity, Excluding VIE | ||||||||||||||||||||
| Total loans to Policyholders | ||||||||||||||||||||
| Other Investments | ||||||||||||||||||||
| Consolidated Entity, Excluding VIE | ||||||||||||||||||||
| Total other Investments | ||||||||||||||||||||
| Consolidated Entity, Excluding VIE | ||||||||||||||||||||
| Total Investments | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Consolidated Entity, Excluding VIE | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total cash | ||||||||||||||||||||
| Receivables from Policyholders | ||||||||||||||||||||
| Consolidated Entity, Excluding VIE | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total receivables from Policyholders | ||||||||||||||||||||
| Other Receivables | ||||||||||||||||||||
| Consolidated Entity, Excluding VIE | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total other Receivables | ||||||||||||||||||||
| Deferred Policy Acquisition Costs | ||||||||||||||||||||
| Consolidated Entity, Excluding VIE | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total deferred Policy Acquisition Costs | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Consolidated Entity, Excluding VIE | ||||||||||||||||||||
| Total goodwill | ||||||||||||||||||||
| Current Income Tax Assets | ||||||||||||||||||||
| Consolidated Entity, Excluding VIE | ||||||||||||||||||||
| Total current Income Tax Assets | ||||||||||||||||||||
| Deferred Income Tax Assets | ||||||||||||||||||||
| Consolidated Entity, Excluding VIE | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total deferred Income Tax Assets | ||||||||||||||||||||
| Other Assets | ||||||||||||||||||||
| Consolidated Entity, Excluding VIE | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total other Assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities and Shareholders’ Equity: | ||||||||||||||||||||
| Insurance Reserves: | ||||||||||||||||||||
| Life and Health | ||||||||||||||||||||
| Property and Casualty | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total property and Casualty | ||||||||||||||||||||
| Life and Health | ||||||||||||||||||||
| Property and Casualty | ||||||||||||||||||||
| Consolidated Entity, Excluding VIE | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total insurance Reserves | ||||||||||||||||||||
| Unearned Premiums | ||||||||||||||||||||
| Consolidated Entity, Excluding VIE | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total unearned Premiums | ||||||||||||||||||||
| Policyholder Obligations | ||||||||||||||||||||
| Consolidated Entity, Excluding VIE | ||||||||||||||||||||
| Total policyholder Obligations | ||||||||||||||||||||
| Deferred Income Tax Liabilities | ||||||||||||||||||||
| Consolidated Entity, Excluding VIE | ||||||||||||||||||||
| Total deferred Income Tax Liabilities | ||||||||||||||||||||
| Accrued Expenses and Other Liabilities | ||||||||||||||||||||
| Consolidated Entity, Excluding VIE | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total accrued Expenses and Other Liabilities | ||||||||||||||||||||
| Long-term Debt, Current and Non-current, at Amortized Cost (Fair Value: 2023 - $1,213.4; 2022 - $1,195.1) | ||||||||||||||||||||
| Long-term Debt, Current, at Amortized Cost | ||||||||||||||||||||
| Consolidated Entity, Excluding VIE | ||||||||||||||||||||
| Total long-term Debt, Current, at Amortized Cost | ||||||||||||||||||||
| Long-term Debt, Non-Current, at Amortized Cost | ||||||||||||||||||||
| Consolidated Entity, Excluding VIE | ||||||||||||||||||||
| Total long-term Debt, Non-Current, at Amortized Cost | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Kemper Corporation Shareholders’ Equity: | ||||||||||||||||||||
| Common Stock, $0.10 Par Value, 100,000,000 Shares Authorized; 58,922,222 Shares Issued and Outstanding at June 30, 2026 and 58,666,644 Shares Issued and Outstanding at December 31, 2025 | ||||||||||||||||||||
| Paid-in Capital | ||||||||||||||||||||
| Retained Earnings | ||||||||||||||||||||
| Accumulated Other Comprehensive Loss | ||||||||||||||||||||
| Total Kemper Corporation Shareholders’ Equity | ||||||||||||||||||||
| Noncontrolling Interest | ||||||||||||||||||||
| Total Shareholders’ Equity | ||||||||||||||||||||
| Total Liabilities and Shareholders’ Equity | ||||||||||||||||||||
Loading...